Almeda Ventures Limited Partnership vs Veeva Systems Inc Class A: Fair Value & Quality
Both stocks run through our valuation models. Here is how Almeda Ventures Limited Partnership (AMDA) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 28, 2026.
As of Aug 28, 2026, Fair Value Calculator sees Almeda Ventures Limited Partnership as the less overvalued of the two: Almeda Ventures Limited Partnership trades at ILS 2.45 versus a fair value of ILS 1.41 (-42%), while Veeva Systems Inc Class A trades at $282 versus $91.49 (-68%).
Almeda Ventures Limited Partnership
AMDA.TA · ILA · Health Care
-42%
upside to fair value
overvalued
PriceILS 2.45
Fair ValueILS 1.41
Quality59/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-68%
upside to fair value
overvalued
Price$282
Fair Value$91.49
Quality72/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Almeda Ventures Limited PartnershipVeeva Systems Inc Class A
Valuation
—P/E (TTM)33.6×
1.49×P/S (TTM)9.31×
0.62×P/B4.28×
1.6×EV/EBITDA28.7×
—PEG0.85×
0.0%Dividend yield0.0%
ILS 0.09Dividend per share—
Profitability
93%Net margin28%
95%Operating margin31%
38%Return on equity14%
24%Return on assets7%
Growth
0%Revenue growth (YoY)16%
-54.1%Avg. growth/yr (3Y)14.0%
—Avg. growth/yr (5Y)16.9%
Balance & size
$16MMarket cap$31B
weakGrowth qualityhealthy
Almeda Ventures Limited Partnership leads: 7 to 2 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Almeda Ventures Limited Partnershipof which business quality 53 · market factors 83Veeva Systems Inc Class Aof which business quality 72 · market factors 60
ProfitabilityMargins and returns on capital today
38
57
Quality GrowthAre margins and returns improving?
80
65
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
100
33
Low VolatilityCalm price path (market factor)
69
52
MomentumPrice trend over the last 3–12 months (market factor)
85
67
52W MomentumDistance to the 52-week high (market factor)
97
57
Net IssuanceBuybacks instead of dilution
0
72
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Almeda Ventures Limited Partnership
Earnings-BasedILS 0.72
MultiplesILS 1.52
Asset-BasedILS 0.89
Economic ProfitILS 0.81
Growth EarningsILS 1.62
12 of 12 models see the stock below the current price.
Veeva Systems Inc Class A
DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Almeda Ventures Limited Partnership
Bear ILS 1.05Fair Value ILS 1.41Bull ILS 1.76
ILS 2.45 = current price (white tick)
Veeva Systems Inc Class A
Bear $70.65Fair Value $91.49Bull $138
$282 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Almeda Ventures Limited Partnership · Health Care
Quality score59 · above median
Fair value upside-42% · below median
Veeva Systems Inc Class A · Health Care
Quality score72 · Top 25%
Fair value upside-68% · bottom 25%
Bottom line
As of Aug 28, 2026, Fair Value Calculator sees Almeda Ventures Limited Partnership as the less overvalued of the two: Almeda Ventures Limited Partnership trades at ILS 2.45 versus a fair value of ILS 1.41 (-42%), while Veeva Systems Inc Class A trades at $282 versus $91.49 (-68%).
Veeva Systems Inc Class A has the higher quality score (72/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.
